Sofituzumab Vedotin
Sofituzumab Vedotin Uses, Dosage, Side Effects, Food Interaction and all others data.
Sofituzumab Vedotin is under investigation in clinical trial NCT01335958 (Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer).
| Trade Name | Sofituzumab Vedotin |
| Generic | Sofituzumab vedotin |
| Sofituzumab vedotin Other Names | DMUC5754A, Sofituzumab vedotin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Sofituzumab Vedotin
